- Deferiprone Related Arthropathy in 11-Year-Old Boy with Hereditary Spherocytosis
-
Seo YK, Han JK, Suh WS, Park KB
- KMID: 2470422
- Soonchunhyang Med Sci.
- 2019 Dec;25(2):155-158.
- doi: 10.0000/sms.2019.25.2.155
Regular transfusion therapy in children with intractable hematologic disorder results in hemosiderosis. It causes several organ damages such as liver, heart, and endocrine system and increases risk of infection. Thus,... -
- CITED
-
- Close
- SHARE
-
- Close
- A Patient with Beta-Propeller Protein-Associated Neurodegeneration: Treatment with Iron Chelation Therapy
-
Lim SY, Tan AH, Ahmad-Annuar A, Schneider , Bee PC, Lim JL, Ramli N, Idris MI
- KMID: 2413381
- J Mov Disord.
- 2018 May;11(2):89-92.
- doi: 10.14802/jmd.17082
We present a case of beta-propeller protein-associated neurodegeneration, a form of neurodegeneration with brain iron accumulation. The patient harbored a novel mutation in the WDR45 gene. A detailed video and... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and safety of deferiprone (Ferriprox), an oral iron-chelating agent, in pediatric patients
-
Won SC, Han DK, Seo JJ, Chung NG, Park SK, Park KB, Kook H, Lyu CJ
- KMID: 2252088
- Korean J Hematol.
- 2010 Mar;45(1):58-61.
- doi: 10.5045/kjh.2010.45.1.58
BACKGROUND: Iron overload is a predictable and life-threatening complication in patients dependent on the regular transfusion of RBCs. The aims of this study were to investigate the efficacy and safety... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of Iron-Chelator Deferiprone on the In Vitro Growth of Staphylococci
-
Kim CM, Shin SH
- KMID: 1779132
- J Korean Med Sci.
- 2009 Apr;24(2):289-295.
- doi: 10.3346/jkms.2009.24.2.289
The standard iron-chelator deferoxamine is known to prevent the growth of coagulase-negative staphylococci (CoNS) which are major pathogens in iron-overloaded patients. However, we found that deferoxamine rather promotes the growth... -
- CITED
-
- Close
- SHARE
-
- Close
